Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|April 11, 2022
Leukemia's Next Top Model? Syngeneic Models to Advance Adoptive Cellular TherapyJaquelyn T Zoine, Sarah E Moore, M Paulina Velasquez
Oncoimmunology|August 16, 2019
Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine modelJaquelyn T Zoine, Kristopher A Knight, Lauren C Fleischer, et al.
Cytotherapy|November 10, 2020
Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemiaJamie Y Story, Jaquelyn T Zoine, Rebecca E Burnham, et al.
Molecular Therapy. Methods & Clinical Development|June 18, 2021
Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIIIAthena L Russell, Chengyu Prince, Taran S Lundgren, et al.
Frontiers in Medicine|December 7, 2020
Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell ImmunotherapyRebecca E Burnham, Jaquelyn T Zoine, Jamie Y Story, et al.
Gene Therapy|August 13, 2021
Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cellsJaquelyn T Zoine, Chengyu Prince, Jamie Y Story, et al.
Cell Reports. Medicine|February 13, 2024
Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificityJaquelyn T Zoine, Kalyan Immadisetty, Jorge Ibanez-Vega, et al.
Blood|January 27, 2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicityChristopher Ronald Funk, Shuhua Wang, Kevin Z Chen, et al.
Blood|August 1, 2022
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignanciesAbdullah Freiwan, Jaquelyn T Zoine, Jeremy Chase Crawford, et al.
Pageof 1